387 related articles for article (PubMed ID: 16899521)
1. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
[TBL] [Abstract][Full Text] [Related]
2. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
[TBL] [Abstract][Full Text] [Related]
3. CCR7 signaling inhibits T cell proliferation.
Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
[TBL] [Abstract][Full Text] [Related]
4. Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model.
Yamashita N; Tashimo H; Matsuo Y; Ishida H; Yoshiura K; Sato K; Yamashita N; Kakiuchi T; Ohta K
J Allergy Clin Immunol; 2006 May; 117(5):1040-6. PubMed ID: 16675330
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of CCL19 impairs alloimmune response in mice.
Krautwald S; Ziegler E; Förster R; Ohl L; Amann K; Kunzendorf U
Immunology; 2004 Jun; 112(2):301-9. PubMed ID: 15147573
[TBL] [Abstract][Full Text] [Related]
6. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.
Walker SR; Ogagan PD; DeAlmeida D; Aboka AM; Barksdale EM
J Pediatr Surg; 2006 Jan; 41(1):260-5. PubMed ID: 16410144
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
[TBL] [Abstract][Full Text] [Related]
9. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
Britschgi MR; Favre S; Luther SA
Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
[TBL] [Abstract][Full Text] [Related]
10. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
[TBL] [Abstract][Full Text] [Related]
11. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.
Pahuja A; Maki RA; Hevezi PA; Chen A; Verge GM; Lechner SM; Roth RB; Zlotnik A; Alleva DG
Scand J Immunol; 2006 Oct; 64(4):361-9. PubMed ID: 16970675
[TBL] [Abstract][Full Text] [Related]
13. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
[TBL] [Abstract][Full Text] [Related]
14. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
15. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.
Schumann K; Lämmermann T; Bruckner M; Legler DF; Polleux J; Spatz JP; Schuler G; Förster R; Lutz MB; Sorokin L; Sixt M
Immunity; 2010 May; 32(5):703-13. PubMed ID: 20471289
[TBL] [Abstract][Full Text] [Related]
16. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.
Kellermann SA; Hudak S; Oldham ER; Liu YJ; McEvoy LM
J Immunol; 1999 Apr; 162(7):3859-64. PubMed ID: 10201903
[TBL] [Abstract][Full Text] [Related]
17. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.
Jeannin P; Magistrelli G; Herbault N; Goetsch L; Godefroy S; Charbonnier P; Gonzalez A; Delneste Y
Eur J Immunol; 2003 Feb; 33(2):326-33. PubMed ID: 12548563
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CCR7 leads to decreased dendritic cell migration to draining lymph nodes and promotes graft survival in low-risk corneal transplantation.
Hos D; Dörrie J; Schaft N; Bock F; Notara M; Kruse FE; Krautwald S; Cursiefen C; Bachmann BO
Exp Eye Res; 2016 May; 146():1-6. PubMed ID: 26689751
[TBL] [Abstract][Full Text] [Related]
19. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.
Iijima N; Yanagawa Y; Clingan JM; Onoé K
Int Immunol; 2005 Sep; 17(9):1201-12. PubMed ID: 16027136
[TBL] [Abstract][Full Text] [Related]
20. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
Tateyama M; Fujihara K; Misu T; Itoyama Y
J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
